BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rong Z, Rong Y, Li Y, Zhang L, Peng J, Zou B, Zhou N, Pan Z. Development of a Novel Six-miRNA-Based Model to Predict Overall Survival Among Colon Adenocarcinoma Patients. Front Oncol 2020;10:26. [PMID: 32154160 DOI: 10.3389/fonc.2020.00026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Wu M, Lou W, Lou M, Fu P, Yu XF. Integrated Analysis of Distant Metastasis-Associated Genes and Potential Drugs in Colon Adenocarcinoma. Front Oncol 2020;10:576615. [PMID: 33194689 DOI: 10.3389/fonc.2020.576615] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Miao Y, Li Q, Sun G, Wang L, Zhang D, Xu H, Xu Z. MiR-5683 suppresses glycolysis and proliferation through targeting pyruvate dehydrogenase kinase 4 in gastric cancer. Cancer Med 2020;9:7231-43. [PMID: 32780563 DOI: 10.1002/cam4.3344] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Gong X, Liu Y, Zheng C, Tian P, Peng M, Pan Y, Li X. Establishment of a 4-miRNA Prognostic Model for Risk Stratification of Patients With Pancreatic Adenocarcinoma. Front Oncol 2022;12:827259. [PMID: 35186758 DOI: 10.3389/fonc.2022.827259] [Reference Citation Analysis]
4 Yang M, He H, Peng T, Lu Y, Yu J, Khan R. Identification of 9 Gene Signatures by WGCNA to Predict Prognosis for Colon Adenocarcinoma. Computational Intelligence and Neuroscience 2022;2022:1-15. [DOI: 10.1155/2022/8598046] [Reference Citation Analysis]
5 Huang G, Yang Y, Lv M, Huang T, Zhan X, Yao Y, Hou J. miR-23b-3p Inhibits the Oncogenicity of Colon Adenocarcinoma by Directly Targeting NFE2L3. J Oncol 2021;2021:8493225. [PMID: 34966429 DOI: 10.1155/2021/8493225] [Reference Citation Analysis]
6 Lu Y, Wu S, Cui C, Yu M, Wang S, Yue Y, Liu M, Sun Z. Gene Expression Along with Genomic Copy Number Variation and Mutational Analysis Were Used to Develop a 9-Gene Signature for Estimating Prognosis of COAD. Onco Targets Ther 2020;13:10393-408. [PMID: 33116619 DOI: 10.2147/OTT.S255590] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Zhao W, Liu X. MiR-3682 promotes the progression of hepatocellular carcinoma (HCC) via inactivating AMPK signaling by targeting ADRA1A. Ann Hepatol 2021;:100570. [PMID: 34706275 DOI: 10.1016/j.aohep.2021.100570] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]